Michèle Himmelspach

759 total citations
16 papers, 642 citations indexed

About

Michèle Himmelspach is a scholar working on Molecular Biology, Genetics and Virology. According to data from OpenAlex, Michèle Himmelspach has authored 16 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Virology. Recurrent topics in Michèle Himmelspach's work include Virus-based gene therapy research (4 papers), HIV Research and Treatment (3 papers) and RNA and protein synthesis mechanisms (3 papers). Michèle Himmelspach is often cited by papers focused on Virus-based gene therapy research (4 papers), HIV Research and Treatment (3 papers) and RNA and protein synthesis mechanisms (3 papers). Michèle Himmelspach collaborates with scholars based in Austria, France and Germany. Michèle Himmelspach's co-authors include Dorian Bevec, Herbert Jaksche, G. King Farrington, Hans Christian Probst, Michael Rühl, H.N. Aschauer, F Hammerschmid, Barbara Wolff, G M Bahr and Friedrich Dorner and has published in prestigious journals such as Science, Genes & Development and The Journal of Cell Biology.

In The Last Decade

Michèle Himmelspach

15 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michèle Himmelspach Austria 11 465 156 87 79 79 16 642
Wilhelm Bannwarth Switzerland 8 323 0.7× 135 0.9× 220 2.5× 98 1.2× 37 0.5× 11 705
Marika Dobrovnik Austria 11 418 0.9× 264 1.7× 177 2.0× 101 1.3× 112 1.4× 11 635
A. Darveau Canada 12 812 1.7× 83 0.5× 139 1.6× 95 1.2× 94 1.2× 14 1.0k
Sohrab Khan United States 12 348 0.7× 229 1.5× 117 1.3× 80 1.0× 123 1.6× 18 587
F T Gates United States 10 505 1.1× 157 1.0× 264 3.0× 138 1.7× 60 0.8× 14 823
Phaik‐Mooi Leong United States 7 354 0.8× 102 0.7× 82 0.9× 143 1.8× 90 1.1× 8 626
E. Heimer United States 10 325 0.7× 173 1.1× 100 1.1× 56 0.7× 69 0.9× 19 559
N. Kluge Germany 10 287 0.6× 71 0.5× 126 1.4× 174 2.2× 82 1.0× 24 616
Mary K. Short United States 13 330 0.7× 176 1.1× 155 1.8× 119 1.5× 124 1.6× 24 709
Benjamin Rovinski Canada 14 442 1.0× 329 2.1× 127 1.5× 131 1.7× 162 2.1× 22 843

Countries citing papers authored by Michèle Himmelspach

Since Specialization
Citations

This map shows the geographic impact of Michèle Himmelspach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michèle Himmelspach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michèle Himmelspach more than expected).

Fields of papers citing papers by Michèle Himmelspach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michèle Himmelspach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michèle Himmelspach. The network helps show where Michèle Himmelspach may publish in the future.

Co-authorship network of co-authors of Michèle Himmelspach

This figure shows the co-authorship network connecting the top 25 collaborators of Michèle Himmelspach. A scholar is included among the top collaborators of Michèle Himmelspach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michèle Himmelspach. Michèle Himmelspach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Himmelspach, Michèle, et al.. (2002). A Fully Recombinant Partial Prothrombin Complex Effectively Bypasses fVIII In Vitro and In Vivo. Thrombosis and Haemostasis. 88(12). 1003–1011. 14 indexed citations
2.
Plaimauer, Barbara, et al.. (2001). ‘Shed’ furin: mapping of the cleavage determinants and identification of its C-terminus. Biochemical Journal. 354(3). 689–689. 30 indexed citations
3.
Plaimauer, Barbara, et al.. (2001). ‘Shed’ furin: mapping of the cleavage determinants and identification of its C-terminus. Biochemical Journal. 354(3). 689–695. 28 indexed citations
4.
Himmelspach, Michèle, Michael Pfleiderer, Bernhard Fischer, et al.. (2000). Recombinant Human Factor X. Thrombosis Research. 97(2). 51–67. 17 indexed citations
5.
Mohr, Gabriele, et al.. (2000). Permanent mycoplasma removal from tissue culture cells: A genetic approach. Biotechnology and Bioprocess Engineering. 5(2). 84–91. 1 indexed citations
6.
Schlokat, Uwe, Gabriele Mohr, Michèle Himmelspach, et al.. (1999). Strategies for recombinant Furin employment in a biotechnological process: complete target protein precursor cleavage. Cytotechnology. 30(1-3). 1–16. 13 indexed citations
7.
Fischer, B., Uwe Schlokat, Michèle Himmelspach, & Friedrich Dorner. (1998). Binding of hirudin to meizothrombin. Protein Engineering Design and Selection. 11(8). 715–721. 13 indexed citations
8.
Hämmerle, Thomas, Michèle Himmelspach, Friedrich Dorner, & Falko G. Falkner. (1997). A sensitive PCR assay system for the quantitation of viral genome equivalents: human immunodeficiency virus type 1 (HIV-1) and hepatitis B virus (HBV). Archives of Virology. 142(7). 1297–1306. 10 indexed citations
9.
Himmelspach, Michèle, Franz Gruber, Gerhard Antoine, et al.. (1996). Specific Quantitation of Genomic DNA in the Femtogram Range by Amplification of Repetitive Sequences. Analytical Biochemistry. 242(2). 240–247. 4 indexed citations
10.
Bevec, Dorian, Herbert Jaksche, Martin Oft, et al.. (1996). Inhibition of HIV-1 Replication in Lymphocytes by Mutants of the Rev Cofactor eIF-5A. Science. 271(5257). 1858–1860. 180 indexed citations
11.
Mohr, Gabriele, et al.. (1996). Production of highly homogeneous and structurally intact recombinant von Willebrand factor multimers by furin‐mediated propeptide removal in vitro. Biotechnology and Applied Biochemistry. 24(3). 257–267. 15 indexed citations
12.
Himmelspach, Michèle, Yvon Cavaloc, K. Chebli, James Stévenin, & Renata Gattoni. (1995). Titration of serine/arginine (SR) splicing factors during adenoviral infection modulates E1A pre-mRNA alternative splicing.. PubMed. 1(8). 794–806. 37 indexed citations
13.
Rühl, Michael, Michèle Himmelspach, G M Bahr, et al.. (1993). Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation.. The Journal of Cell Biology. 123(6). 1309–1320. 244 indexed citations
14.
Gattoni, Renata, K. Chebli, Michèle Himmelspach, & James Stévenin. (1991). Modulation of alternative splicing of adenoviral E1A transcripts: factors involved in the early-to-late transition.. Genes & Development. 5(10). 1847–1858. 27 indexed citations
15.
Himmelspach, Michèle, et al.. (1991). Differential Block of U Small Nuclear Ribonucleoprotein Particle Interactions during In Vitro Splicing of Adenovirus E1A Transcripts Containing Abnormally Short Introns. Molecular and Cellular Biology. 11(3). 1258–1269. 3 indexed citations
16.
Himmelspach, Michèle, et al.. (1991). Differential block of U small nuclear ribonucleoprotein particle interactions during in vitro splicing of adenovirus E1A transcripts containing abnormally short introns.. Molecular and Cellular Biology. 11(3). 1258–1269. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wilhelm Bannwarth Breakdown of academic impact, for papers by Marika Dobrovnik Breakdown of academic impact, for papers by A. Darveau Breakdown of academic impact, for papers by Sohrab Khan Breakdown of academic impact, for papers by F T Gates Breakdown of academic impact, for papers by Phaik‐Mooi Leong Breakdown of academic impact, for papers by E. Heimer Breakdown of academic impact, for papers by N. Kluge Breakdown of academic impact, for papers by Mary K. Short Breakdown of academic impact, for papers by Benjamin Rovinski
Rankless by CCL
2026